C1584: Effect on von willebrand factor proteolysis and von willebrand factor antigen levels

Acta Haematologica

Volumn 121, Issue 2-3, 2009, Pages 98-101

  Davies, James Anthony ^a   Collins, Peter William ^a   Hathaway, Lee Sarah ^a   Bowen, Derrick John ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ADAMTS13; Blood group O; C1584; Proteolysis; Y C1584

Indexed keywords

MEMBRANE PROTEIN; PROTEIN C1584; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR C1584; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN;

BLOOD CLOT; BLOOD GROUP O; DNA SEQUENCE; GENE LOCUS; GENOTYPE; HETEROZYGOSITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SUBSTITUTION; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; CHEMISTRY; COHORT ANALYSIS; GENETICS; METABOLIC CLEARANCE RATE; METABOLISM; MISSENSE MUTATION; PENETRANCE; PHENOTYPE; POINT MUTATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; RECESSIVE GENE; VON WILLEBRAND DISEASE;

ABO BLOOD-GROUP SYSTEM; ADAM PROTEINS; AMINO ACID SUBSTITUTION; BLOOD COAGULATION; COHORT STUDIES; GENES, RECESSIVE; GENOTYPE; HUMANS; METABOLIC CLEARANCE RATE; MUTATION, MISSENSE; PENETRANCE; PHENOTYPE; POINT MUTATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 67649649805     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214848     Document Type: Review

References (12)

1. O'Brien LA, James PD, Othman M, Berber E, Cameron C, Notley CR, Hegadorn CA, Sutherland JJ, Hough C, Rivard GE, O'Shaunessey D, Lillicrap D: Association of Hemophilia Clinic Directors of Canada. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003;102:549-557.
2. Bowen DJ, Collins PW: An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood 2004; 103: 941-947.
3. Bowen DJ: An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003;1:33-40.
4. O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA: Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood 2005;106: 1988-1991.
5. Bowen DJ, Collins PW: Insights into von Willebra nd factor proteolysis: clinica limplications. Br J Haematol 2006;133:457-467.
6. Bowen DJ, Collins PW, Lester W, Cumming AM, Keene y S, Grundy P, Enay at SM, Bolton-Maggs PH, Keeling DM, Khair K, Tait RC, Wilde JT, Pasi KJ, Hill FG: UK Haemophilia Centre Doctors' Organization. The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. Br J Haematol 2005;128:830-836.
7. Keeney S, Grundy P, Collins PW, Bowen DJ: C1584 in von Willebrand factor is necessary for enhanced proteolysis by ADAMTS13 in vitro. Haemophilia 2007; 13: 405-408.
8. Davies JA, Collins PW, Hathaway L, Bowen DJ: The effect of von Willebrand factor Y/ C1584 on in vivo protein level and function, and interaction with ABO blood group. Blood 2007; 109:2840-2846.
9. Budde U: Phenotypic classification of von Willebrand disease. Haematol Rep 2005; 1: 9-15.
10. Davies JA, Collins PW, Hathaway L, Bowen DJ: Von Willebrand factor: evidence for variable clearance in vivo according to Y/C1584 phenotype and ABO blood group. J Thromb Haemost 2008; 6:97-103.
11. Haberichter SL, Balistreri M, Christopherson P, Morateck P, Gavazova S, Bellissimo DB, Manco-Johnson MJ, Gill JC, Montgomery RR: Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood 2006; 108: 3344-3351.
12. Eikenboom JCJ, Castaman G, Kamphuisen PW, Rosendaal FR, Bertina RM: The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor. Thromb Haemost 2002; 87:252-257.